Alnylam Pharmaceuticals
ALNY
#565
Rank
HK$327.25 B
Marketcap
HK$2,468
Share price
-1.75%
Change (1 day)
30.00%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company